Drug discovery for inflammatory diseases

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.3, Iss.6, 2003-09, pp. : 1001-1004

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Evaluating Protein-protein Interaction (PPI) Networks for Diseases Pathway, Target Discovery, and Drug-design Using ‘In silico Pharmacology’

Current Protein and Peptide Science, Vol. 15, Iss. 6, 2014-09 ,pp. : 561-571

Bentham Science Publishers

Access to resources Recommend Favorite

Hemozoin and antimalarial drug discovery

By Fong Kim Y Wright David W

Future Medicinal Chemistry, Vol. 5, Iss. 12, 2013-08 ,pp. : 1437-1450

Future Science

Access to resources Recommend Favorite

Immunotherapeutic approaches to inflammatory bowel diseases

By Holtmann M.H. Galle P.R. Neurath M.F.

Expert Opinion on Biological Therapy, Vol. 1, Iss. 3, 2001-05 ,pp. : 455-466

Informa Healthcare

Access to resources Recommend Favorite

Immunotherapy for autoimmune and inflammatory renal diseases

By Booth Anthony D Firth John D Jayne David RW

Expert Opinion on Biological Therapy, Vol. 3, Iss. 3, 2003-06 ,pp. : 487-500

Informa Healthcare

Access to resources Recommend Favorite

Proteomic Insights into Inflammatory Airway Diseases

Current Proteomics, Vol. 8, Iss. 2, 2011-07 ,pp. : 84-96

Bentham Science Publishers

Access to resources Recommend Favorite